WallStreetZenWallStreetZen

NASDAQ: EVGN
Evogene Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their EVGN stock forecasts and price targets.

Forecast return on equity

Is EVGN forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is EVGN forecast to generate an efficient return on assets?

Company
N/A
Industry
8.86%

EVGN earnings per share forecast

What is EVGN's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.38
Avg 2 year Forecast
-$1.02

EVGN revenue forecast

What is EVGN's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$1.5M-60.29%
Avg 2 year Forecast
$2.7M-31.17%
Avg 3 year Forecast
$5.0M+31.04%
EVGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EVGN revenue growth forecast

How is EVGN forecast to perform vs Biotechnology companies and vs the US market?

Company
-10.64%
Industry
47.14%
Market
15.18%
EVGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EVGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EVGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EVGN$0.85N/AN/A
PMCB$0.69N/AN/A
PPBT$3.98$30.00+653.77%Buy
XBIO$3.26N/AN/A
TCRT$3.22N/AN/A
View Top Biotech Stocks

Evogene Stock Forecast FAQ

What is EVGN's earnings growth forecast for 2026-2027?

(NASDAQ: EVGN) Evogene's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.41%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 75.66%.

Evogene's earnings in 2026 is -$8,485,000.On average, 3 Wall Street analysts forecast EVGN's earnings for 2026 to be -$12,002,497, with the lowest EVGN earnings forecast at -$11,531,810, and the highest EVGN earnings forecast at -$12,355,511.

In 2027, EVGN is forecast to generate -$8,890,738 in earnings, with the lowest earnings forecast at -$8,542,082 and the highest earnings forecast at -$9,152,231.

If you're new to stock investing, here's how to buy Evogene stock.

What is EVGN's revenue growth forecast for 2026-2028?

(NASDAQ: EVGN) Evogene's forecast annual revenue growth rate of -10.64% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 47.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.18%.

Evogene's revenue in 2026 is $3,853,000.On average, 3 Wall Street analysts forecast EVGN's revenue for 2026 to be $13,336,107, with the lowest EVGN revenue forecast at $12,813,123, and the highest EVGN revenue forecast at $13,728,346. On average, 3 Wall Street analysts forecast EVGN's revenue for 2027 to be $23,115,919, with the lowest EVGN revenue forecast at $22,209,413, and the highest EVGN revenue forecast at $23,795,799.

In 2028, EVGN is forecast to generate $44,009,154 in revenue, with the lowest revenue forecast at $42,283,305 and the highest revenue forecast at $45,307,899.

What is EVGN's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: EVGN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 8.86%.

What is EVGN's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: EVGN) Evogene's current Earnings Per Share (EPS) is -$1.08. On average, analysts forecast that EVGN's EPS will be -$1.38 for 2026, with the lowest EPS forecast at -$1.32, and the highest EPS forecast at -$1.42. In 2027, EVGN's EPS is forecast to hit -$1.02 (min: -$0.98, max: -$1.05).

What is EVGN's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: EVGN) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.